The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Martin E. Stryjewski

Department of Medicine and Division of Infectious Diseases

Centro de Educación Médica e Investigaciones Clínicas (CEMIC)

Buenos Aires



Name/email consistency: high



  • Department of Medicine and Division of Infectious Diseases, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina. 2009 - 2012
  • Division of Infectious Diseases, Duke Clinical Research Institute, Durham, North Carolina, USA. 2009
  • Duke Clinical Research Institute, Duke University Medical Center, Durham, USA. 2006 - 2009
  • Division of Infectious Diseases and International Health, Department of Medicine, Duke University School of Medicine, Durham, USA. 2003


  1. TD-1792 versus vancomycin for treatment of complicated skin and skin structure infections. Stryjewski, M.E., Potgieter, P.D., Li, Y.P., Barriere, S.L., Churukian, A., Kingsley, J., Corey, G.R. Antimicrob. Agents Chemother. (2012) [Pubmed]
  2. New treatments for methicillin-resistant Staphylococcus aureus. Stryjewski, M.E., Corey, G.R. Curr. Opin. Crit. Care (2009) [Pubmed]
  3. Staphylococcus aureus bacteremia among patients with health care-associated fever. Stryjewski, M.E., Kanafani, Z.A., Chu, V.H., Pappas, P.A., Harding, T., Drew, L.A., Benjamin, D.K., Reller, L.B., Lee, B.A., Corey, G.R., Fowler, V.G. Am. J. Med. (2009) [Pubmed]
  4. Gram-negative bloodstream infections. Stryjewski, M.E., Boucher, H.W. Int. J. Antimicrob. Agents (2009) [Pubmed]
  5. Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms. Stryjewski, M.E., Graham, D.R., Wilson, S.E., O'Riordan, W., Young, D., Lentnek, A., Ross, D.P., Fowler, V.G., Hopkins, A., Friedland, H.D., Barriere, S.L., Kitt, M.M., Corey, G.R. Clin. Infect. Dis. (2008) [Pubmed]
  6. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Stryjewski, M.E., Chambers, H.F. Clin. Infect. Dis. (2008) [Pubmed]
  7. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Stryjewski, M.E., Szczech, L.A., Benjamin, D.K., Inrig, J.K., Kanafani, Z.A., Engemann, J.J., Chu, V.H., Joyce, M.J., Reller, L.B., Corey, G.R., Fowler, V.G. Clin. Infect. Dis. (2007) [Pubmed]
  8. Expression of antimicrobial peptides in the normal and involved skin of patients with infective cellulitis. Stryjewski, M.E., Hall, R.P., Chu, V.H., Kanafani, Z.A., O'Riordan, W.D., Weinstock, M.S., Stienecker, R.S., Streilein, R., Dorschner, R.A., Fowler, V.G., Corey, G.R., Gallo, R.L. J. Infect. Dis. (2007) [Pubmed]
  9. Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study. Stryjewski, M.E., Chu, V.H., O'Riordan, W.D., Warren, B.L., Dunbar, L.M., Young, D.M., Vallée, M., Fowler, V.G., Morganroth, J., Barriere, S.L., Kitt, M.M., Corey, G.R. Antimicrob. Agents Chemother. (2006) [Pubmed]
  10. Sepsis, multiple organ failure, and death due to Pandoraea pnomenusa infection after lung transplantation. Stryjewski, M.E., LiPuma, J.J., Messier, R.H., Reller, L.B., Alexander, B.D. J. Clin. Microbiol. (2003) [Pubmed]
WikiGenes - Universities